Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Marrow Diseases × Sertraline × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Classical hematology 1

Conditions

Preleukemia 1 Myelodysplastic Syndromes 1 Leukemia 1 Hematologic Diseases 1 Cytopenia 1 Bone Marrow Diseases 1 Anemia 1

Interventions

11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 Sertraline 1 Bone Marrow Transplantation 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02452983 2022-06-02

SS1

Baylor College of Medicine

Phase 1 Terminated

Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Anemia, Bone Marrow Diseases, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Preleukemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡